{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T19:23:51Z","timestamp":1766690631189,"version":"3.40.3"},"publisher-location":"Cham","reference-count":86,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030576158"},{"type":"electronic","value":"9783030576165"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-57616-5_7","type":"book-chapter","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T10:04:02Z","timestamp":1603188242000},"page":"87-103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Treatment of Necrotizing Soft Tissue Infections: Antibiotics"],"prefix":"10.1007","author":[{"given":"Oddvar","family":"Oppegaard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eivind","family":"Rath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"key":"7_CR1","first-page":"269","volume":"215","author":"F Andreoni","year":"2017","unstructured":"Andreoni F, Zurcher C, Tarnutzer A, Schilcher K, Neff A, Keller N, Marques Maggio E, Poyart C, Schuepbach RA, Zinkernagel AS (2017) Clindamycin affects group A streptococcus virulence factors and improves clinical outcome. J Infect Dis 215:269\u2013277","journal-title":"J Infect Dis"},{"key":"7_CR2","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/jac\/dkz520","volume":"75","author":"FCS Arnaud","year":"2020","unstructured":"Arnaud FCS, Liborio AB (2020) Attributable nephrotoxicity of vancomycin in critically ill patients: a marginal structural model study. J Antimicrob Chemother 75:1031\u20131037","journal-title":"J Antimicrob Chemother"},{"key":"7_CR3","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ijantimicag.2010.01.023","volume":"35","author":"A Barbour","year":"2010","unstructured":"Barbour A, Scaglione F, Derendorf H (2010) Class-dependent relevance of tissue distribution in the interpretation of anti-infective pharmacokinetic\/pharmacodynamic indices. Int J Antimicrob Agents 35:431\u2013438","journal-title":"Int J Antimicrob Agents"},{"key":"7_CR4","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1128\/AAC.50.3.841-851.2006","volume":"50","author":"M Barcia-Macay","year":"2006","unstructured":"Barcia-Macay M, Seral C, Mingeot-Leclercq MP, Tulkens PM, van Bambeke F (2006) Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages. Antimicrob Agents Chemother 50:841\u2013851","journal-title":"Antimicrob Agents Chemother"},{"key":"7_CR5","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/infdis\/jiz167","volume":"220","author":"J Baude","year":"2019","unstructured":"Baude J, Bastien S, Gillet Y, Leblanc P, Itzek A, Tristan A, Bes M, Duguez S, Moreau K, Diep BA, Norrby-Teglund A, Henry T, Vandenesch F, Group IS (2019) Necrotizing soft tissue infection Staphylococcus aureus but not S. pyogenes isolates display high rates of internalization and cytotoxicity toward human myoblasts. J Infect Dis 220:710\u2013719","journal-title":"J Infect Dis"},{"key":"7_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013260","volume":"7","author":"R Brindle","year":"2017","unstructured":"Brindle R, Williams OM, Davies P, HARRIS T, Jarman H, Hay AD, Featherstone P (2017) Adjunctive clindamycin for cellulitis: a clinical trial comparing flucloxacillin with or without clindamycin for the treatment of limb cellulitis. BMJ Open 7:e013260","journal-title":"BMJ Open"},{"issue":"9","key":"7_CR7","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jamadermatol.2019.0884","volume":"155","author":"R Brindle","year":"2019","unstructured":"Brindle R, Williams OM, Barton E, Featherstone P (2019) Assessment of antibiotic treatment of cellulitis and erysipelas: a systematic review and meta-analysis. JAMA Dermatol 155(9):1033\u20131040","journal-title":"JAMA Dermatol"},{"key":"7_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1177\/000992288502400606","volume":"24","author":"I Brook","year":"1985","unstructured":"Brook I, Hirokawa R (1985) Treatment of patients with a history of recurrent tonsillitis due to group A beta-hemolytic streptococci. A prospective randomized study comparing penicillin, erythromycin, and clindamycin. Clin Pediatr 24:331\u2013336","journal-title":"Clin Pediatr"},{"key":"7_CR9","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1128\/CMR.00086-12","volume":"26","author":"I Brook","year":"2013","unstructured":"Brook I, Wexler HM, Goldstein EJ (2013) Antianaerobic antimicrobials: spectrum and susceptibility testing. Clin Microbiol Rev 26:526\u2013546","journal-title":"Clin Microbiol Rev"},{"key":"7_CR10","doi-asserted-by":"publisher","unstructured":"Bruun T, Rath E, Bruun Madsen M, Oppegaard O, Nekludov M, Arnell P, Karlsson Y, Babbar A, Bergey F, Itzek A, Hyldegaard O, Norrby-Teglund A, Skrede S; Group IS (2020) Risk factors and predictors of mortality in streptococcal necrotizing soft-tissue infections: a multicenter prospective study. Clin Infect Dis. \n                https:\/\/doi.org\/10.1093\/cid\/ciaa027","DOI":"10.1093\/cid\/ciaa027"},{"key":"7_CR11","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1128\/AAC.00925-16","volume":"60","author":"JP Burnham","year":"2016","unstructured":"Burnham JP, Burnham CA, Warren DK, Kollef MH (2016) Impact of time to appropriate therapy on mortality in patients with vancomycin-intermediate Staphylococcus aureus infection. Antimicrob Agents Chemother 60:5546\u20135553","journal-title":"Antimicrob Agents Chemother"},{"key":"7_CR12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/cid\/ciu304","volume":"59","author":"JR Carapetis","year":"2014","unstructured":"Carapetis JR, Jacoby P, Carville K, Ang SJ, Curtis N, Andrews R (2014) Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections. Clin Infect Dis 59:358\u2013365","journal-title":"Clin Infect Dis"},{"key":"7_CR13","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1093\/ofid\/ofy347","volume":"6","author":"M Castanheira","year":"2019","unstructured":"Castanheira M, Deshpande LM, Mendes RE, Canton R, Sader HS, Jones RN (2019) Variations in the occurrence of resistance phenotypes and carbapenemase genes among enterobacteriaceae isolates in 20 years of the SENTRY antimicrobial surveillance program. Open Forum Infect Dis 6:S23\u2013S33","journal-title":"Open Forum Infect Dis"},{"key":"7_CR14","first-page":"1","volume":"2010","author":"CDCgov","year":"2010","unstructured":"CDCgov (2010) Prevention of perinatal group B streptococcal disease, revised guidelines from CDC. MMWR Morb Mortal Wkly Rep 2010:1\u201332","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"7_CR15","doi-asserted-by":"publisher","first-page":"6413982","DOI":"10.1155\/2016\/6413982","volume":"2016","author":"D Chai","year":"2016","unstructured":"Chai D, Liu X, Wang R, Bai Y, Cai Y (2016) Efficacy of linezolid and fosfomycin in catheter-related biofilm infection caused by methicillin-resistant Staphylococcus aureus. Biomed Res Int 2016:6413982","journal-title":"Biomed Res Int"},{"key":"7_CR16","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1128\/JCM.41.9.4043-4048.2003","volume":"41","author":"J Conley","year":"2003","unstructured":"Conley J, Olson ME, Cook LS, Ceri H, Phan V, Davies HD (2003) Biofilm formation by group a streptococci: is there a relationship with treatment failure? J Clin Microbiol 41:4043\u20134048","journal-title":"J Clin Microbiol"},{"key":"7_CR17","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1592\/phco.23.5.638.32191","volume":"23","author":"EA Coyle","year":"2003","unstructured":"Coyle EA, Society of Infectious Diseases, P (2003) Targeting bacterial virulence: the role of protein synthesis inhibitors in severe infections. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy 23:638\u2013642","journal-title":"Pharmacotherapy"},{"key":"7_CR18","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1128\/AAC.47.5.1752-1755.2003","volume":"47","author":"EA Coyle","year":"2003","unstructured":"Coyle EA, Cha R, Rybak MJ (2003) Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin a release. Antimicrob Agents Chemother 47:1752\u20131755","journal-title":"Antimicrob Agents Chemother"},{"key":"7_CR19","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1128\/AAC.00461-08","volume":"52","author":"S Dahesh","year":"2008","unstructured":"Dahesh S, Hensler ME, van Sorge NM, Gertz RE, Schrag S, Nizet V, Beall BW (2008) Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics. Antimicrob Agents Chemother 52:2915\u20132918","journal-title":"Antimicrob Agents Chemother"},{"key":"7_CR20","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/1471-2334-12-348","volume":"12","author":"DK Das","year":"2012","unstructured":"Das DK, Baker MG, Venugopal K (2012) Risk factors, microbiological findings and outcomes of necrotizing fasciitis in New Zealand: a retrospective chart review. BMC Infect Dis 12:348","journal-title":"BMC Infect Dis"},{"key":"7_CR21","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1086\/529148","volume":"46","author":"AM Dechet","year":"2008","unstructured":"Dechet AM, Yu PA, Koram N, Painter J (2008) Nonfoodborne Vibrio infections: an important cause of morbidity and mortality in the United States, 1997-2006. Clin Infect Dis 46:970\u2013976","journal-title":"Clin Infect Dis"},{"issue":"7","key":"7_CR22","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00355-19","volume":"63","author":"DJ Diekema","year":"2019","unstructured":"Diekema DJ, Hsueh PR, Mendes RE, Pfaller MA, Rolston KV, Sader HS, Jones RN (2019a) The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother 63(7):e00355","journal-title":"Antimicrob Agents Chemother"},{"key":"7_CR23","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1093\/ofid\/ofy270","volume":"6","author":"DJ Diekema","year":"2019","unstructured":"Diekema DJ, Pfaller MA, Shortridge D, Zervos M, Jones RN (2019b) Twenty-year trends in antimicrobial susceptibilities among Staphylococcus aureus from the SENTRY antimicrobial surveillance program. Open Forum Infect Dis 6:S47\u2013S53","journal-title":"Open Forum Infect Dis"},{"key":"7_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jgar.2019.07.007","volume":"20","author":"LR Duncan","year":"2019","unstructured":"Duncan LR, Smith CJ, Flamm RK, Mendes RE (2019) Regional analysis of telavancin and comparator antimicrobial activity against multidrug-resistant Staphylococcus aureus collected in the USA 2014-2016. J Glob Antimicrob Resist 20:118\u2013123","journal-title":"J Glob Antimicrob Resist"},{"key":"7_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0002-9343(52)90293-3","volume":"13","author":"H Eagle","year":"1952","unstructured":"Eagle H (1952) Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice. Am J Med 13:389\u2013399","journal-title":"Am J Med"},{"key":"7_CR26","unstructured":"eCDC (2019) Surveillance of antimicrobial resistance in Europe 2018. European Centre for Disease Prevention and Control. \n                https:\/\/www.ecdc.europa.eu\/en\/publications-data\/surveillance-antimicrobial-resistance-europe-2018\n                \n              . Accessed 26 March 2020"},{"key":"7_CR27","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1089\/sur.2015.238","volume":"17","author":"I Faraklas","year":"2016","unstructured":"Faraklas I, Yang D, Eggerstedt M, Zhai Y, Liebel P, Graves G, Dissanaike S, Mosier M, Cochran A (2016) A multi-center review of care patterns and outcomes in necrotizing soft tissue infections. Surg Infect 17:773\u2013778","journal-title":"Surg Infect"},{"key":"7_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ijantimicag.2012.12.013","volume":"41","author":"DJ Farrell","year":"2013","unstructured":"Farrell DJ, Flamm RK, Sader HS, Jones RN (2013) Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe. Int J Antimicrob Agents 41:337\u2013342","journal-title":"Int J Antimicrob Agents"},{"key":"7_CR29","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1097\/CCM.0000000000000330","volume":"42","author":"R Ferrer","year":"2014","unstructured":"Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, Artigas A, Schorr C, Levy MM (2014) Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 42:1749\u20131755","journal-title":"Crit Care Med"},{"key":"7_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fcimb.2015.00015","volume":"5","author":"T Fiedler","year":"2015","unstructured":"Fiedler T, Koller T, Kreikemeyer B (2015) Streptococcus pyogenes biofilms-formation, biology, and clinical relevance. Front Cell Infect Microbiol 5:15","journal-title":"Front Cell Infect Microbiol"},{"key":"7_CR31","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1093\/jac\/dkw320","volume":"71","author":"K Fuursted","year":"2016","unstructured":"Fuursted K, Stegger M, Hoffmann S, Lambertsen L, Andersen PS, Deleuran M, Thomsen MK (2016) Description and characterization of a penicillin-resistant Streptococcus dysgalactiae subsp. equisimilis clone isolated from blood in three epidemiologically linked patients. J Antimicrob Chemother 71:3376\u20133380","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"7_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/antibiotics6040025","volume":"6","author":"M Gajdacs","year":"2017","unstructured":"Gajdacs M, Spengler G, Urban E (2017) Identification and antimicrobial susceptibility testing of anaerobic bacteria: Rubik\u2019s cube of clinical microbiology? Antibiotics 6(4):25","journal-title":"Antibiotics"},{"key":"7_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e02192","volume":"5","author":"G Gebreyohannes","year":"2019","unstructured":"Gebreyohannes G, Nyerere A, Bii C, Sbhatu DB (2019) Challenges of intervention, treatment, and antibiotic resistance of biofilm-forming microorganisms. Heliyon 5:e02192","journal-title":"Heliyon"},{"key":"7_CR34","unstructured":"Helsedirektoratet (2013) Norwegian national guidelines for antimicrobial treatment of necrotizing soft tissue infections. \n                https:\/\/www.helsedirektoratet.no\/retningslinjer\/antibiotika-i-sykehus\/hud-og-blotdelsinfeksjoner\/nekrotiserende-blotdelsinfeksjoner?malgruppe=undefined\n                \n              . Accessed 26 March 2020"},{"key":"7_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035218","volume":"7","author":"E Hertzen","year":"2012","unstructured":"Hertzen E, Johansson L, Kansal R, Hecht A, Dahesh S, Janos M, Nizet V, Kotb M, Norrby-Teglund A (2012) Intracellular Streptococcus pyogenes in human macrophages display an altered gene expression profile. PLoS One 7:e35218","journal-title":"PLoS One"},{"key":"7_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227748","volume":"15","author":"CT Hsiao","year":"2020","unstructured":"Hsiao CT, Chang CP, Huang TY, Chen YC, Fann WC (2020) Prospective validation of the laboratory risk indicator for necrotizing fasciitis (LRINEC) score for necrotizing fasciitis of the extremities. PLoS One 15:e0227748","journal-title":"PLoS One"},{"key":"7_CR37","unstructured":"JANIS (2018) Annual surveillance report on antimicrobial resistance in Japan: 2018. \n                https:\/\/janis.mhlw.go.jp\/english\/report\/index.html\n                \n              . Accessed 26 March 2020"},{"key":"7_CR38","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1086\/508773","volume":"43","author":"EL Kaplan","year":"2006","unstructured":"Kaplan EL, Chhatwal GS, Rohde M (2006) Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications. Clin Infect Dis 43:1398\u20131406","journal-title":"Clin Infect Dis"},{"key":"7_CR39","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s40262-014-0152-3","volume":"53","author":"TK Kiang","year":"2014","unstructured":"Kiang TK, Hafeli UO, Ensom MH (2014) A comprehensive review on the pharmacokinetics of antibiotics in interstitial fluid spaces in humans: implications on dosing and clinical pharmacokinetic monitoring. Clin Pharmacokinet 53:695\u2013730","journal-title":"Clin Pharmacokinet"},{"key":"7_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218668","volume":"14","author":"T Kim","year":"2019","unstructured":"Kim T, Park SY, Kwak YG, Jung J, Kim MC, Choi SH, Yu SN, Hong HL, Kim YK, Park SY, Song EH, Park KH, Cho OH, Choi SH, Korean SSG (2019) Etiology, characteristics, and outcomes of community-onset necrotizing fasciitis in Korea: a multicenter study. PLoS One 14:e0218668","journal-title":"PLoS One"},{"issue":"7","key":"7_CR41","doi-asserted-by":"publisher","first-page":"520","DOI":"10.7326\/L19-0133","volume":"171","author":"M King","year":"2019","unstructured":"King M, Rose L, Fraimow H, Nagori M, Danish M, Doktor K (2019) Vibrio vulnificus infections from a previously nonendemic area. Ann Intern Med 171(7):520\u2013521","journal-title":"Ann Intern Med"},{"key":"7_CR42","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3947\/ic.2017.49.4.301","volume":"49","author":"YG Kwak","year":"2017","unstructured":"Kwak YG, Choi SH, Kim T, Park SY, Seo SH, Kim MB, Choi SH (2017) Clinical guidelines for the antibiotic treatment for community-acquired skin and soft tissue infection. Infect Chemother 49:301\u2013325","journal-title":"Infect Chemother"},{"key":"7_CR43","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/0002-9343(83)90434-5","volume":"75","author":"K Lam","year":"1983","unstructured":"Lam K, Bayer AS (1983) Serious infections due to group G streptoccocci. Report of 15 cases with in vitro-in vivo correlations. Am J Med 75:561\u2013570","journal-title":"Am J Med"},{"key":"7_CR44","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.amjsurg.2007.08.047","volume":"194","author":"TC Lee","year":"2007","unstructured":"Lee TC, Carrick MM, Scott BG, Hodges JC, Pham HQ (2007) Incidence and clinical characteristics of methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a large urban hospital. Am J Surg 194:809\u2013812","journal-title":"Am J Surg"},{"key":"7_CR45","doi-asserted-by":"publisher","first-page":"18033","DOI":"10.1038\/nrdp.2018.33","volume":"4","author":"AS Lee","year":"2018","unstructured":"Lee AS, de Lencastre H, Garau J, Kluytmans J, Malhotra-Kumar S, Peschel A, Harbarth S (2018) Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers 4:18033","journal-title":"Nat Rev Dis Primers"},{"key":"7_CR46","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1128\/AAC.01877-13","volume":"58","author":"JS Lewis","year":"2014","unstructured":"Lewis JS, Lepak AJ, Thompson GR, Craig WA, Andes DR, Sabol-Dzintars KE, Jorgensen JH (2014) Failure of clindamycin to eradicate infection with beta-hemolytic streptococci inducibly resistant to clindamycin in an animal model and in human infections. Antimicrob Agents Chemother 58:1327\u20131331","journal-title":"Antimicrob Agents Chemother"},{"key":"7_CR47","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/cid\/ciu449","volume":"59","author":"A Linner","year":"2014","unstructured":"Linner A, Darenberg J, Sjolin J, Henriques-Normark B, Norrby-Teglund A (2014) Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Clin Infect Dis 59:851\u2013857","journal-title":"Clin Infect Dis"},{"key":"7_CR48","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, Talan DA, Chambers HF, Infectious Diseases Society of, A (2011) Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 52:e18\u2013e55","journal-title":"Clin Infect Dis"},{"key":"7_CR49","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jss.2019.05.006","volume":"243","author":"A Louis","year":"2019","unstructured":"Louis A, Savage S, Utter GH, Li SW, Crandall M (2019) NSTI organisms and regions: a multicenter study from the American Association for the Surgery of Trauma. J Surg Res 243:108\u2013113","journal-title":"J Surg Res"},{"key":"7_CR50","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.3389\/fmicb.2017.01052","volume":"8","author":"B Lu","year":"2017","unstructured":"Lu B, Fang Y, Fan Y, Chen X, Wang J, Zeng J, Li Y, Zhang Z, Huang L, Li H, Li D, Zhu F, Cui Y, Wang D (2017) High prevalence of macrolide-resistance and molecular characterization of Streptococcus pyogenes isolates circulating in China from 2009 to 2016. Front Microbiol 8:1052","journal-title":"Front Microbiol"},{"key":"7_CR51","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00134-019-05730-x","volume":"45","author":"MB Madsen","year":"2019","unstructured":"Madsen MB, Skrede S, Perner A, Arnell P, Nekludov M, Bruun T, Karlsson Y, Hansen MB, Polzik P, Hedetoft M, Rosen A, Saccenti E, Bergey F, Martins Dos Santos VAP, Norrby-Teglund A, Hyldegaard O, Group IS (2019) Patient\u2019s characteristics and outcomes in necrotising soft-tissue infections: results from a Scandinavian, multicentre, prospective cohort study. Intensive Care Med 45:1241\u20131251","journal-title":"Intensive Care Med"},{"key":"7_CR52","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0924-8579(01)00413-7","volume":"18","author":"EM Mascini","year":"2001","unstructured":"Mascini EM, Jansze M, Schouls LM, Verhoef J, van Dijk H (2001) Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci. Int J Antimicrob Agents 18:395\u2013398","journal-title":"Int J Antimicrob Agents"},{"key":"7_CR53","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jinf.2007.04.007","volume":"55","author":"M Melzer","year":"2007","unstructured":"Melzer M, Petersen I (2007) Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. J Infect 55:254\u2013259","journal-title":"J Infect"},{"key":"7_CR54","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJMoa042683","volume":"352","author":"LG Miller","year":"2005","unstructured":"Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS, Tang AW, Phung TO, Spellberg B (2005) Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352:1445\u20131453","journal-title":"N Engl J Med"},{"key":"7_CR55","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s40262-016-0463-7","volume":"56","author":"IK Minichmayr","year":"2017","unstructured":"Minichmayr IK, Schaeftlein A, Kuti JL, Zeitlinger M, Kloft C (2017) Clinical determinants of target non-attainment of linezolid in plasma and interstitial space fluid: a pooled population pharmacokinetic analysis with focus on critically ill patients. Clin Pharmacokinet 56:617\u2013633","journal-title":"Clin Pharmacokinet"},{"key":"7_CR56","unstructured":"NORM\/NORM-VET (2018) Usage og antimicrobial agents and occurrence of antimicrobial resistance in Norway. \n                https:\/\/unn.no\/fag-og-forskning\/norm-norsk-overvakingssystem-for-antibiotikaresistens-hos-mikrober\n                \n              . Accessed 26 Mar 2020"},{"key":"7_CR57","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cmi.2014.08.019","volume":"21","author":"O Oppegaard","year":"2015","unstructured":"Oppegaard O, Mylvaganam H, Kittang BR (2015) Beta-haemolytic group A, C and G streptococcal infections in Western Norway: a 15-year retrospective survey. Clin Microbiol Infect 21:171\u2013178","journal-title":"Clin Microbiol Infect"},{"key":"7_CR58","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/QCO.0000000000000256","volume":"29","author":"F Pea","year":"2016","unstructured":"Pea F (2016) Practical concept of pharmacokinetics\/pharmacodynamics in the management of skin and soft tissue infections. Curr Opin Infect Dis 29:153\u2013159","journal-title":"Curr Opin Infect Dis"},{"key":"7_CR59","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cmi.2019.06.031","volume":"26","author":"M Peetermans","year":"2020","unstructured":"Peetermans M, de Prost N, Eckmann C, Norrby-Teglund A, Skrede S, de Waele JJ (2020) Necrotizing skin and soft-tissue infections in the intensive care unit. Clin Microbiol Infect 26:8\u201317","journal-title":"Clin Microbiol Infect"},{"key":"7_CR60","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4321\/S1130-01082012000400002","volume":"104","author":"L Perianez-Parraga","year":"2012","unstructured":"Perianez-Parraga L, Martinez-Lopez I, Ventayol-Bosch P, Puigventos-Latorre F, Delgado-Sanchez O (2012) Drug dosage recommendations in patients with chronic liver disease. Rev Esp Enferm Dig 104:165\u2013184","journal-title":"Rev Esp Enferm Dig"},{"key":"7_CR61","unstructured":"Public Health England (2018) Laboratory surveillance of pyogenic and non-pyogenic streptococcal bacteraemia in England, Wales and Northern Ireland: 2017. Health Protection Report, 41"},{"key":"7_CR62","unstructured":"Rigshospitalet (2020) Danish guidelines for antimicrobial treatment of necrotizing soft tissue infections. \n                https:\/\/www.rigshospitalet.dk\/afdelinger-og-klinikker\/diagnostisk\/klinisk-mikrobiologisk-afdeling\/for_fagfolk\/Sider\/retningslinjer-for-antibiotika.aspx\n                \n              . Accessed 26 March 2020"},{"key":"7_CR63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2431-12-3","volume":"12","author":"AL Roberts","year":"2012","unstructured":"Roberts AL, Connolly KL, Kirse DJ, Evans AK, Poehling KA, Peters TR, Reid SD (2012) Detection of group A Streptococcus in tonsils from pediatric patients reveals high rate of asymptomatic streptococcal carriage. BMC Pediatr 12:3","journal-title":"BMC Pediatr"},{"key":"7_CR64","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/jac\/13.4.389","volume":"13","author":"KV Rolston","year":"1984","unstructured":"Rolston KV, Chandrasekar PH, Lefrock JL (1984) Antimicrobial tolerance in group C and group G streptococci. J Antimicrob Chemother 13:389\u2013392","journal-title":"J Antimicrob Chemother"},{"key":"7_CR65","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13017-018-0219-9","volume":"13","author":"M Sartelli","year":"2018","unstructured":"Sartelli M, Guirao X, Hardcastle TC, Kluger Y, Boermeester MA, Rasa K, Ansaloni L, Coccolini F, Montravers P, Abu-Zidan FM, Bartoletti M, Bassetti M, Ben-Ishay O, Biffl WL, Chiara O, Chiarugi M, Coimbra R, de Rosa FG, de Simone B, di Saverio S, Giannella M, Gkiokas G, Khokha V, Labricciosa FM, Leppaniemi A, Litvin A, Moore EE, Negoi I, Pagani L, Peghin M, Picetti E, Pintar T, Pupelis G, Rubio-Perez I, Sakakushev B, Segovia-Lohse H, Sganga G, Shelat V, Sugrue M, Tarasconi A, Trana C, Ulrych J, Viale P, Catena F (2018) 2018 WSES\/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections. World J Emerg Surg 13:58","journal-title":"World J Emerg Surg"},{"key":"7_CR66","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/toxins11060332","volume":"11","author":"P Shumba","year":"2019","unstructured":"Shumba P, Mairpady Shambat S, Siemens N (2019) The Role of Streptococcal and Staphylococcal exotoxins and proteases in human necrotizing soft tissue infections. Toxins 11:6","journal-title":"Toxins"},{"key":"7_CR67","doi-asserted-by":"publisher","first-page":"16945","DOI":"10.1038\/srep16945","volume":"5","author":"N Siemens","year":"2015","unstructured":"Siemens N, Kittang BR, Chakrakodi B, Oppegaard O, Johansson L, Bruun T, Mylvaganam H, Svensson M, Skrede S, Norrby-Teglund A, Group IS (2015) Increased cytotoxicity and streptolysin O activity in group G streptococcal strains causing invasive tissue infections. Sci Rep 5:16945","journal-title":"Sci Rep"},{"key":"7_CR68","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.87882","volume":"1","author":"N Siemens","year":"2016","unstructured":"Siemens N, Chakrakodi B, Shambat SM, Morgan M, Bergsten H, Hyldegaard O, Skrede S, Arnell P, Madsen MB, Johansson L, Juarez J, Bosnjak L, Morgelin M, Svensson M, Norrby-Teglund A, Group IS (2016) Biofilm in group A streptococcal Necrotizing soft tissue infections. JCI Insight 1:e87882","journal-title":"JCI Insight"},{"key":"7_CR69","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1128\/AAC.50.4.1372-1375.2006","volume":"50","author":"K Skhirtladze","year":"2006","unstructured":"Skhirtladze K, Hutschala D, Fleck T, Thalhammer F, Ehrlich M, Vukovich T, Muller M, Tschernko EM (2006) Impaired target site penetration of vancomycin in diabetic patients following cardiac surgery. Antimicrob Agents Chemother 50:1372\u20131375","journal-title":"Antimicrob Agents Chemother"},{"key":"7_CR70","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1086\/600296","volume":"49","author":"B Spellberg","year":"2009","unstructured":"Spellberg B, Talbot GH, Boucher HW, Bradley JS, Gilbert D, Scheld WM, Edwards J, Bartlett JG, Antimicrobial Availability Task Force of the Infectious Diseases Society of A (2009) Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials. Clin Infect Dis 49:383\u2013391","journal-title":"Clin Infect Dis"},{"key":"7_CR71","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1056\/NEJMra1600673","volume":"377","author":"DL Stevens","year":"2017","unstructured":"Stevens DL, Bryant AE (2017) Necrotizing soft-tissue infections. N Engl J Med 377:2253\u20132265","journal-title":"N Engl J Med"},{"key":"7_CR72","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/infdis\/158.1.23","volume":"158","author":"DL Stevens","year":"1988","unstructured":"Stevens DL, Gibbons AE, Bergstrom R, Winn V (1988) The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 158:23\u201328","journal-title":"J Infect Dis"},{"key":"7_CR73","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.anaerobe.2011.11.001","volume":"18","author":"DL Stevens","year":"2012","unstructured":"Stevens DL, Aldape MJ, Bryant AE (2012) Life-threatening clostridial infections. Anaerobe 18:254\u2013259","journal-title":"Anaerobe"},{"key":"7_CR74","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1093\/cid\/ciu296","volume":"59","author":"DL Stevens","year":"2014","unstructured":"Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC, Infectious Diseases Society of A (2014) Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 59:e10\u2013e52","journal-title":"Clin Infect Dis"},{"key":"7_CR75","first-page":"345","volume":"17","author":"C Sunderkotter","year":"2019","unstructured":"Sunderkotter C, Becker K, Eckmann C, Graninger W, Kujath P, Schofer H (2019) S2k guidelines for skin and soft tissue infections Excerpts from the S2k guidelines for \u201ccalculated initial parenteral treatment of bacterial infections in adults - update 2018\u201d. J Dtsch Dermatol Ges 17:345\u2013369","journal-title":"J Dtsch Dermatol Ges"},{"key":"7_CR76","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1038\/s41467-019-11722-8","volume":"10","author":"R Thanert","year":"2019","unstructured":"Thanert R, Itzek A, Hossmann J, Hamisch D, Madsen MB, Hyldegaard O, Skrede S, Bruun T, Norrby-Teglund A, Medina E, Pieper DH, Group IS (2019) Molecular profiling of tissue biopsies reveals unique signatures associated with streptococcal necrotizing soft tissue infections. Nat Commun 10:3846","journal-title":"Nat Commun"},{"key":"7_CR77","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1080\/20009666.2019.1651482","volume":"9","author":"R Tirupathi","year":"2019","unstructured":"Tirupathi R, Areti S, Salim SA, Palabindala V, Jonnalagadda N (2019) Acute bacterial skin and soft tissue infections: new drugs in ID armamentarium. J Commun Hosp Intern Med Perspect 9:310\u2013313","journal-title":"J Commun Hosp Intern Med Perspect"},{"key":"7_CR78","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1007\/s00134-013-3088-4","volume":"39","author":"AA Udy","year":"2013","unstructured":"Udy AA, Roberts JA, Lipman J (2013) Clinical implications of antibiotic pharmacokinetic principles in the critically ill. Intensive Care Med 39:2070\u20132082","journal-title":"Intensive Care Med"},{"key":"7_CR79","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13613-019-0598-4","volume":"9","author":"T Urbina","year":"2019","unstructured":"Urbina T, Hua C, Sbidian E, Bosc R, Tomberli F, Lepeule R, Decousser JW, Mekontso Dessap A, Chosidow O, de Prost N, Henri Mondor Hospital Necrotizing Fasciitis, G (2019) Impact of a multidisciplinary care bundle for necrotizing skin and soft tissue infections: a retrospective cohort study. Ann Intensive Care 9:123","journal-title":"Ann Intensive Care"},{"key":"7_CR80","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1128\/CMR.05022-11","volume":"25","author":"SJ van Hal","year":"2012","unstructured":"van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB (2012) Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev 25:362\u2013386","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"7_CR81","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/cid\/ciz1000","volume":"71","author":"K Vannice","year":"2019","unstructured":"Vannice K, Ricaldi J, Nanduri S, Fang FC, Lynch J, Bryson-Cahn C, Wright T, Duchin J, Kay M, Chochua S, van Beneden C, Beall B (2019) Streptococcus pyogenes pbp2x mutation confers reduced susceptibility to beta-lactam antibiotics. Clin Infect Dis 71(1):201\u2013204","journal-title":"Clin Infect Dis"},{"key":"7_CR82","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.2106\/00004623-200308000-00005","volume":"85","author":"CH Wong","year":"2003","unstructured":"Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO (2003) Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 85:1454\u20131460","journal-title":"J Bone Joint Surg Am"},{"key":"7_CR83","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1086\/498509","volume":"42","author":"VC Wu","year":"2006","unstructured":"Wu VC, Wang YT, Wang CY, Tsai IJ, Wu KD, Hwang JJ, Hsueh PR (2006) High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease. Clin Infect Dis 42:66\u201372","journal-title":"Clin Infect Dis"},{"key":"7_CR84","volume":"7","author":"J Yue","year":"2016","unstructured":"Yue J, Dong BR, Yang M, Chen X, Wu T, Liu GJ (2016) Linezolid versus vancomycin for skin and soft tissue infections. Cochrane Database Syst Rev 7:CD008056","journal-title":"Cochrane Database Syst Rev"},{"key":"7_CR85","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/apm.12969","volume":"127","author":"HH Zhao-Fleming","year":"2019","unstructured":"Zhao-Fleming HH, Wilkinson JE, Larumbe E, Dissanaike S, Rumbaugh K (2019) Obligate anaerobes are abundant in human necrotizing soft tissue infection samples - a metagenomics analysis. APMIS 127:577\u2013587","journal-title":"APMIS"},{"key":"7_CR86","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/apm.12687","volume":"125","author":"W Zimmerli","year":"2017","unstructured":"Zimmerli W, Sendi P (2017) Orthopaedic biofilm infections. APMIS 125:353\u2013364","journal-title":"APMIS"}],"container-title":["Advances in Experimental Medicine and Biology","Necrotizing Soft Tissue Infections"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-57616-5_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T10:12:15Z","timestamp":1603188735000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-57616-5_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030576158","9783030576165"],"references-count":86,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-57616-5_7","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"21 October 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}